Non-Interventional Study to Observe Treatment Efficacy in Maintaining Symptoms Control in Patients With Schizophrenia, Treated With Seroquel XR.
Phase of Trial: Phase IV
Latest Information Update: 10 Feb 2010
At a glance
- Drugs Quetiapine (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 10 Feb 2010 Actual patient number (578) added as reported by ClinicalTrials.gov.
- 10 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Feb 2010 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.